Cited by 675Cannabis and Cannabinoid ResearchNeuroscience and Neuropharmacology ResearchPharmacological Receptor Mechanisms and Effects

The DOI matches its Crossref record; 183 of the 183 references it cites were found in a registry or an index.

Multiple Functions of Endocannabinoid Signaling in the Brain

Open access

Katona, István, Freund, Tamás F.·2012·Annual Review of Neuroscience

DOI 10.1146/annurev-neuro-062111-150420PMC PMC4273654

Open this paper in CoChat — free account

Abstract

Despite being regarded as a hippie science for decades, cannabinoid research has finally found its well-deserved position in mainstream neuroscience. A series of groundbreaking discoveries revealed that endocannabinoid molecules are as widespread and important as conventional neurotransmitters such as glutamate or GABA, yet they act in profoundly unconventional ways. We aim to illustrate how uncovering the molecular, anatomical, and physiological characteristics of endocannabinoid signaling has revealed new mechanistic insights into several fundamental phenomena in synaptic physiology. First, we summarize unexpected advances in the molecular complexity of biogenesis and inactivation of the two endocannabinoids, anandamide and 2-arachidonoylglycerol. Then, we show how these new metabolic routes are integrated into well-known intracellular signaling pathways. These endocannabinoid-producing signalosomes operate in phasic and tonic modes, thereby differentially governing homeostatic, short-term, and long-term synaptic plasticity throughout the brain. Finally, we discuss how cell type– and synapse-specific refinement of endocannabinoid signaling may explain the characteristic behavioral effects of cannabinoids.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1146/annurev-neuro-062111-150420

Cites

183 of 183 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Isolation and Structure of a Brain Constituent That Binds to the Cannabinoid Receptor
Devane, W. A., Hanuš, L., Breuer, A., Pertwee, R. G., Stevenson, L. A., Griffin, G., Gibson, D., Mandelbaum, A., Etinger, A., & Mechoulam, R. (1992) · Science · doi:10.1126/science.1470919 · Cited by 5,633
Molecular characterization of a peripheral receptor for cannabinoids
Munro, S., Thomas, K. L., & Abu-Shaar, M. (1993) · Nature · doi:10.1038/365061a0 · Cited by 5,092
Structure of a cannabinoid receptor and functional expression of the cloned cDNA
Matsuda, L. A., Lolait, S. J., Brownstein, M. J., Young, A. C., & Bonner, T. I. (1990) · Nature · doi:10.1038/346561a0 · Cited by 5,011
Glycine potentiates the NMDA response in cultured mouse brain neurons
Johnson, J. W., & Ascher, P. (1987) · Nature · doi:10.1038/325529a0 · Cited by 3,182
Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors
Mechoulam, R., Ben-Shabat, S., Hanus, L., Ligumsky, M., Kaminski, N. E., Schatz, A. R., Gopher, A., Almog, S., Martin, B. R., Compton, D. R., et al. (1995) · Biochemical Pharmacology · doi:10.1016/0006-2952(95)00109-d · Cited by 2,913
Determination and characterization of a cannabinoid receptor in rat brain
Devane, W. A., Dysarz, F. A., Johnson, M. R., Melvin, L. S., & Howlett, A. C. (1988) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)09876-1 · Cited by 2,443 · cited 2×
“1C-D) (Devane et al., 1988; Bidaut-Russell et al., 1990).”
Background
Isolation, Structure, and Partial Synthesis of an Active Constituent of Hashish
Gaoni, Y., & Mechoulam, R. (1964) · Journal of the American Chemical Society · doi:10.1021/ja01062a046 · Cited by 2,389
Cannabinoid receptor localization in brain.
Herkenham, M., Lynn, A. B., Little, M. D., Johnson, M. R., Melvin, L. S., de Costa, B. R., & Rice, K. C. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.5.1932 · Cited by 2,321
2-Arachidonoylgylcerol: A Possible Endogenous Cannabinoid Receptor Ligand in Brain
Sugiura, T., Kondo, S., Sukagawa, A., Nakane, S., Shinoda, A., Itoh, K., Yamashita, A., & Waku, K. (1995) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1995.2437 · Cited by 2,196
Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides
Cravatt, B. F., Giang, D. K., Mayfield, S. P., Boger, D. L., Lerner, R. A., & Gilula, N. B. (1996) · Nature · doi:10.1038/384083a0 · Cited by 2,125

Show all 183 references

Research works printed but not linked: 1

Gaoni Y, 1967, Tetrahedron Lett., 12, 1109

Sorted by citations

Endocannabinoid Signaling and Synaptic Function
Castillo, P. E., Younts, T. J., Chávez, A. E., & Hashimotodani, Y. (2012) · Neuron · doi:10.1016/j.neuron.2012.09.020 · Cited by 1,191
The endocannabinoid system and the brain.
Mechoulam, R., & Parker, L. A. (2013) · Annual Review of Psychology · doi:10.1146/annurev-psych-113011-143739 · Cited by 1,090
Hippocampal GABAergic Inhibitory Interneurons
Pelkey, K. A., Chittajallu, R., Craig, M. T., Tricoire, L., Wester, J. C., & McBain, C. J. (2017) · Physiological Reviews · doi:10.1152/physrev.00007.2017 · Cited by 889
Obesity and addiction: Neurobiological overlaps
Volkow, N. D., Wang, G. ‐., Tomasi, D., & Baler, R. D. (2013) · Obesity Reviews · doi:10.1111/j.1467-789x.2012.01031.x · Cited by 800
Neurobiological Interactions Between Stress and the Endocannabinoid System
Morena, M., Patel, S., Bains, J. S., & Hill, M. N. (2015) · Neuropsychopharmacology · doi:10.1038/npp.2015.166 · Cited by 698
The endocannabinoid system in guarding against fear, anxiety and stress
Lutz, B., Marsicano, G., Maldonado, R., & Hillard, C. J. (2015) · Nature reviews. Neuroscience · doi:10.1038/nrn4036 · Cited by 506
GABAA receptors: structure, function, pharmacology, and related disorders
Ghit, A., Assal, D., Al‐Shami, A. S., & Hussein, D. E. E. (2021) · Journal of Genetic Engineering and Biotechnology · doi:10.1186/s43141-021-00224-0 · Cited by 456
Autophagy and Alzheimer’s Disease: From Molecular Mechanisms to Therapeutic Implications
Uddin, M. S., Stachowiak, A., Mamun, A. A., Tzvetkov, N. T., Takeda, S., Atanasov, A. G., Bergantin, L. B., Abdel-Daim, M. M., & Stankiewicz, A. M. (2018) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2018.00004 · Cited by 395
Early phytocannabinoid chemistry to endocannabinoids and beyond
Mechoulam, R., Hanuš, L. O., Pertwee, R., & Howlett, A. C. (2014) · Nature Reviews Neuroscience · doi:10.1038/nrn3811 · Cited by 393
Cannabinoid Receptors in the Central Nervous System: Their Signaling and Roles in Disease
Kendall, D. A., & Yudowski, G. A. (2017) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2016.00294 · Cited by 388
CB1 Receptor Signaling in the Brain: Extracting Specificity from Ubiquity
Busquets-García, A., Bains, J. S., & Marsicano, G. (2017) · Neuropsychopharmacology · doi:10.1038/npp.2017.206 · Cited by 365
Traditional marijuana, high‐potency cannabis and synthetic cannabinoids: increasing risk for psychosis
Murray, R. M., Quigley, H., Quattrone, D., Englund, A., & Forti, M. D. (2016) · World Psychiatry · doi:10.1002/wps.20341 · Cited by 332
Cortical structural differences in major depressive disorder correlate with cell type-specific transcriptional signatures
Li, J., Seidlitz, J., Suckling, J., Fan, F., Ji, G., Meng, Y., Yang, S., Wang, K., Qiu, J., Chen, H., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-21943-5 · Cited by 319
Cannabinoid Type 2 Receptors Mediate a Cell Type-Specific Plasticity in the Hippocampus
Stempel, A. V., Stumpf, A., Zhang, H., ÖZDOĞAN, T., Pannasch, U., Theis, A.-K., Otte, D.-M., Wojtalla, A., Rácz, I., Ponomarenko, A. A., et al. (2016) · Neuron · doi:10.1016/j.neuron.2016.03.034 · Cited by 304
Transcriptomic and morphophysiological evidence for a specialized human cortical GABAergic cell type
Boldog, E., Bakken, T. E., Hodge, R. D., Novotny, M., Aevermann, B. D., Baka, J., Bordé, S., Close, J. L., Diez-Fuertes, F., Ding, S.-L., et al. (2018) · Nature Neuroscience · doi:10.1038/s41593-018-0205-2 · Cited by 291
Autism-Associated Neuroligin-3 Mutations Commonly Disrupt Tonic Endocannabinoid Signaling
Földy, C., Malenka, R. C., & Südhof, T. C. (2013) · Neuron · doi:10.1016/j.neuron.2013.02.036 · Cited by 287
The cannabinoid system and pain
Woodhams, S. G., Chapman, V., Finn, D. P., Hohmann, A. G., & Neugebauer, V. (2017) · Neuropharmacology · doi:10.1016/j.neuropharm.2017.06.015 · Cited by 285
Cannabis use during pregnancy: Pharmacokinetics and effects on child development
Grant, K. S., Petroff, R., Isoherranen, N., Stella, N., & Burbacher, T. M. (2017) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2017.08.014 · Cited by 268
The Role of the Endocannabinoid System in the Brain–Gut Axis
Sharkey, K. A., & Wiley, J. W. (2016) · Gastroenterology · doi:10.1053/j.gastro.2016.04.015 · Cited by 264
A systematic review of the antipsychotic properties of cannabidiol in humans
Iseger, T. A., & Bossong, M. G. (2015) · Schizophrenia Research · doi:10.1016/j.schres.2015.01.033 · Cited by 261
Endocannabinoid-mediated retrograde modulation of synaptic transmission
Ohno‐Shosaku, T., & Kano, M. (2014) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2014.03.017 · Cited by 260
Synaptic functions of endocannabinoid signaling in health and disease
Araque, A., Castillo, P. E., Manzoni, O. J., & Tonini, R. (2017) · Neuropharmacology · doi:10.1016/j.neuropharm.2017.06.017 · Cited by 252
Integrating Endocannabinoid Signaling and Cannabinoids into the Biology and Treatment of Posttraumatic Stress Disorder
Hill, M. N., Campolongo, P., Yehuda, R., & Patel, S. (2017) · Neuropsychopharmacology · doi:10.1038/npp.2017.162 · Cited by 248
Role of sphingolipids in the biogenesis and biological activity of extracellular vesicles
Verderio, C., Gabrielli, M., & Giussani, P. (2018) · Journal of Lipid Research · doi:10.1194/jlr.r083915 · Cited by 242
The Role of the Endocannabinoid System and Genetic Variation in Adolescent Brain Development
Meyer, H. C., Lee, F. S., & Gee, D. G. (2017) · Neuropsychopharmacology · doi:10.1038/npp.2017.143 · Cited by 238
The Spectrum of Achalasia: Lessons From Studies of Pathophysiology and High-Resolution Manometry
Kahrilas, P. J., & Boeckxstaens, G. E. (2013) · Gastroenterology · doi:10.1053/j.gastro.2013.08.038 · Cited by 236
How does cannabidiol (CBD) influence the acute effects of delta-9-tetrahydrocannabinol (THC) in humans? A systematic review
Freeman, A. M., Petrilli, K., Lees, R., Hindocha, C., Mokrysz, C., Curran, H. V., Saunders, R., & Freeman, T. P. (2019) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2019.09.036 · Cited by 232
Amygdala FAAH and anandamide: mediating protection and recovery from stress
Gunduz-Cinar, O., Hill, M. N., McEwen, B. S., & Holmes, A. (2013) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2013.08.008 · Cited by 229
Cell-specific STORM super-resolution imaging reveals nanoscale organization of cannabinoid signaling
Dudok, B., Barna, L., Ledri, M., Szabó, S. I., Szabadits, E., Pintér, B., Woodhams, S. G., Henstridge, C. M., Balla, G. Y., Nyilas, R., et al. (2015) · Nature Neuroscience · doi:10.1038/nn.3892 · Cited by 227
Self-citation
The Role of the Endocannabinoid System in Pain
Woodhams, S. G., Sagar, D. R., Burston, J. J., & Chapman, V. (2015) · Handbook of experimental pharmacology · doi:10.1007/978-3-662-46450-2_7 · Cited by 216
The Endocannabinoid System: Pivotal Orchestrator of Obesity and Metabolic Disease
Mazier, W., Saucisse, N., Gatta‐Cherifi, B., & Cota, D. (2015) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2015.07.007 · Cited by 214
Cannabis-associated psychosis: Neural substrate and clinical impact
Murray, R. M., Englund, A., Abi‐Dargham, A., Lewis, D. A., Forti, M. D., Davies, C., Sherif, M. A., McGuire, P. K., & D’Souza, D. C. (2017) · Neuropharmacology · doi:10.1016/j.neuropharm.2017.06.018 · Cited by 210
Regulation of nausea and vomiting by cannabinoids and the endocannabinoid system
Sharkey, K. A., Darmani, N. A., & Parker, L. A. (2013) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2013.09.068 · Cited by 204
Endocannabinoid modulation of dopamine neurotransmission
Covey, D. P., Mateo, Y., Sulzer, D., Cheer, J. F., & Lovinger, D. M. (2017) · Neuropharmacology · doi:10.1016/j.neuropharm.2017.04.033 · Cited by 197
Anandamide and other N-acylethanolamines: A class of signaling lipids with therapeutic opportunities
Mock, E. D., Gagestein, B., & van der Stelt, M. (2022) · Progress in Lipid Research · doi:10.1016/j.plipres.2022.101194 · Cited by 164
Large-Scale 3D Two-Photon Imaging of Molecularly Identified CA1 Interneuron Dynamics in Behaving Mice
Geiller, T., Vancura, B., Terada, S., Troullinou, E., Chavlis, S., Tsagkatakis, G., Tsakalides, P., Ócsai, K., Poirazi, P., Rózsa, B. J., et al. (2020) · Neuron · doi:10.1016/j.neuron.2020.09.013 · Cited by 158
The endocannabinoid system: An emotional buffer in the modulation of memory function
Morena, M., & Campolongo, P. (2014) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2013.12.010 · Cited by 153
Endogenous cannabinoid release within prefrontal-limbic pathways affects memory consolidation of emotional training
Morena, M., Roozendaal, B., Trezza, V., Ratano, P., Peloso, A., Hauer, D., Atsak, P., Trabace, L., Cuomo, V., McGaugh, J. L., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1420285111 · Cited by 150
Mechanisms of Action and Persistent Neuroplasticity by Drugs of Abuse
Korpi, E. R., den Hollander, B., Farooq, U., Vashchinkina, E., Rajkumar, R., Nutt, D. J., Hyytiä, P., & Dawe, G. S. (2015) · Pharmacological Reviews · doi:10.1124/pr.115.010967 · Cited by 148
Cannabinoid type 2 receptors in dopamine neurons inhibits psychomotor behaviors, alters anxiety, depression and alcohol preference
Liu, Q.-R., Canseco-Alba, A., Zhang, H.-Y., Tagliaferro, P., Chung, M., Dennis, E., Sanabria, B., Schanz, N., Escosteguy-Neto, J. C., Ishiguro, H., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-17796-y · Cited by 147
Cannabis Use and the Risk for Psychosis and Affective Disorders
Sideli, L., Quigley, H., Cascia, C. L., & Murray, R. M. (2019) · Journal of Dual Diagnosis · doi:10.1080/15504263.2019.1674991 · Cited by 146
Endocannabinoid System Components as Potential Biomarkers in Psychiatry
Navarrete, F., García‐Gutiérrez, M. S., Barba, R. J., Rubio, G., Gasparyan, A., Austrich-Olivares, A., & Manzanares, J. (2020) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2020.00315 · Cited by 146
Cannabis effects on brain structure, function, and cognition: considerations for medical uses of cannabis and its derivatives
Burggren, A. C., Shirazi, A., Ginder, N., & London, E. D. (2019) · The American Journal of Drug and Alcohol Abuse · doi:10.1080/00952990.2019.1634086 · Cited by 144
A critical role for prefrontocortical endocannabinoid signaling in the regulation of stress and emotional behavior
McLaughlin, R. J., Hill, M. N., & Gorzalka, B. B. (2014) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2014.02.006 · Cited by 142
Weeding out bad waves: towards selective cannabinoid circuit control in epilepsy
Soltész, I., Alger, B. E., Kano, M., Lee, S.-H., Lovinger, D. M., Ohno‐Shosaku, T., & Watanabe, M. (2015) · Nature reviews. Neuroscience · doi:10.1038/nrn3937 · Cited by 142
Control of synaptic function by endocannabinoid-mediated retrograde signaling
Kano, M. (2014) · Proceedings of the Japan Academy Series B · doi:10.2183/pjab.90.235 · Cited by 134
Multiple forms of endocannabinoid and endovanilloid signaling regulate the tonic control of GABA release
Lee, S.-H., Ledri, M., Toth, B., Marchionni, I., Henstridge, C. M., Dudok, B., Kenesei, K., Barna, L., Szabo, S. I., Renkecz, T., et al. (2015) · Journal of Neuroscience · doi:10.1523/jneurosci.4112-14.2015 · Cited by 133
Self-citation
Cannabinoid CB1 receptor in dorsal telencephalic glutamatergic neurons: distinctive sufficiency for hippocampus-dependent and amygdala-dependent synaptic and behavioral functions
Ruehle, S., Remmers, F., Romo-Parra, H., Massa, F., Wickert, M., Wortge, S., Haring, M., Kaiser, N., Marsicano, G., Pape, H.-C., et al. (2013) · Journal of Neuroscience · doi:10.1523/jneurosci.4171-12.2013 · Cited by 132
Anandamide and 2-arachidonoylglycerol: Pharmacological Properties, Functional Features, and Emerging Specificities of the Two Major Endocannabinoids
Luchicchi, A., & Pistis, M. (2012) · Molecular Neurobiology · doi:10.1007/s12035-012-8299-0 · Cited by 129
More surprises lying ahead. The endocannabinoids keep us guessing
Piomelli, D. (2014) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.07.026 · Cited by 128
L ocalization of the cannabinoid type‐1 receptor in subcellular astrocyte compartments of mutant mouse hippocampus
Gutiérrez‐Rodrίguez, A., Río, I. B., Puente, N., Gómez‐Urquijo, S., Fontaine, C. J., Huguet, J. E., Elezgarai, I., Ruehle, S., Lutz, B., Robin, L. M., et al. (2018) · Glia · doi:10.1002/glia.23314 · Cited by 127
Therapeutic endocannabinoid augmentation for mood and anxiety disorders: comparative profiling of FAAH, MAGL and dual inhibitors
Bedse, G., Bluett, R. J., Patrick, T. A., Romness, N. K., Gaulden, A. D., Kingsley, P. J., Plath, N., Marnett, L. J., & Patel, S. (2018) · Translational Psychiatry · doi:10.1038/s41398-018-0141-7 · Cited by 121
Translational evidence for the involvement of the endocannabinoid system in stress-related psychiatric illnesses
Hill, M. N., & Patel, S. (2013) · Biology of Mood & Anxiety Disorders · doi:10.1186/2045-5380-3-19 · Cited by 120
Neurobiology of cannabinoid receptor signaling
Lutz, B. (2020) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2020.22.3/blutz · Cited by 119
Role of the endocannabinoid system in drug addiction
Manzanares, J., Cabañero, D., Puente, N., García‐Gutiérrez, M. S., Grandes, P., & Maldonado, R. J. (2018) · Biochemical Pharmacology · doi:10.1016/j.bcp.2018.09.013 · Cited by 118
Endocannabinoid and Opioid System Interactions in Exercise-Induced Hypoalgesia
Crombie, K. M., Brellenthin, A. G., Hillard, C. J., & Koltyn, K. F. (2017) · Pain Medicine · doi:10.1093/pm/pnx058 · Cited by 117
Neuromodulation of Hippocampal-Prefrontal Cortical Synaptic Plasticity and Functional Connectivity: Implications for Neuropsychiatric Disorders
Ruggiero, R. N., Rossignoli, M. T., Marques, D. B., de Sousa, B. M., Romcy-Pereira, R. N., Lopes-Aguiar, C., & Leite, J. P. (2021) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2021.732360 · Cited by 111
ABHD6 Blockade Exerts Antiepileptic Activity in PTZ-Induced Seizures and in Spontaneous Seizures in R6/2 Mice
Naydenov, A. V., Horne, E. A., Cheah, C. S., Swinney, K., Hsu, K., Cao, J. K., Marrs, W., Blankman, J. L., Tu, S., Cherry, A. E., et al. (2014) · Neuron · doi:10.1016/j.neuron.2014.06.030 · Cited by 111
Dissecting the cannabinergic control of behavior: The where matters
Busquets-García, A., Desprez, T., Metna‐Laurent, M., Bellocchio, L., Marsicano, G., & Gómez, E. S. (2015) · BioEssays · doi:10.1002/bies.201500046 · Cited by 110
Polyunsaturated fatty acid derived signaling in reproduction and development: Insights from Caenorhabditis elegans and Drosophila melanogaster
Vrablik, T. L., & Watts, J. L. (2013) · Molecular Reproduction and Development · doi:10.1002/mrd.22167 · Cited by 106
Endocannabinoid Signaling Collapse Mediates Stress-Induced Amygdalo-Cortical Strengthening
Marcus, D. J., Bedse, G., Gaulden, A. D., Ryan, J. D., Kondev, V., Winters, N. D., Rosas-Vidal, L. E., Altemus, M., Mackie, K., Lee, F. S., et al. (2020) · Neuron · doi:10.1016/j.neuron.2019.12.024 · Cited by 104
Chronic activation of CB2 cannabinoid receptors in the hippocampus increases excitatory synaptic transmission
Kim, J., & Li, Y. (2014) · The Journal of Physiology · doi:10.1113/jphysiol.2014.286633 · Cited by 103
Endocannabinoid-Mediated plasticity in nucleus accumbens controls vulnerability to anxiety after social defeat stress
Bosch-Bouju, C., Larrieu, T., Linders, L., Manzoni, O. J., & Layé, S. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.06.082 · Cited by 100
Functional Relevance of Endocannabinoid-Dependent Synaptic Plasticity in the Central Nervous System
Augustin, S. M., & Lovinger, D. M. (2018) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.7b00508 · Cited by 100
Age-related changes in the endocannabinoid system in the mouse hippocampus
Piyanova, A., Lomazzo, E., Bîndilă, L., Lerner, R., Albayram, Ö., Ruhl, T., Lutz, B., Zimmer, A., & Bilkei‐Gorzó, A. (2015) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2015.08.005 · Cited by 100
Rising stars: Modulation of brain functions by astroglial type‐1 cannabinoid receptors
Metna‐Laurent, M., & Marsicano, G. (2014) · Glia · doi:10.1002/glia.22773 · Cited by 100
CB1 receptor signaling regulates social anxiety and memory
Litvin, Y., Phan, A., Hill, M. N., Pfaff, D. W., & McEwen, B. S. (2013) · Genes Brain & Behavior · doi:10.1111/gbb.12045 · Cited by 99
Astroglial CB1 cannabinoid receptors regulate leptin signaling in mouse brain astrocytes
Bosier, B., Bellocchio, L., Metna‐Laurent, M., Gómez, E. S., Matias, I., Hébert-Chatelain, É., Cannich, A., Maître, M., Lesté-Lasserre, T., Cardinal, P., et al. (2013) · Molecular Metabolism · doi:10.1016/j.molmet.2013.08.001 · Cited by 95
Interplay Between n‐3 and n‐6 Long‐Chain Polyunsaturated Fatty Acids and the Endocannabinoid System in Brain Protection and Repair
Dyall, S. C. (2017) · Lipids · doi:10.1007/s11745-017-4292-8 · Cited by 95
Cannabis: A Treasure Trove or Pandora's Box?
Solymosi, K., & Köfalvi, A. (2016) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/1389557516666161004162133 · Cited by 93
Neuroligin-3: A Circuit-Specific Synapse Organizer That Shapes Normal Function and Autism Spectrum Disorder-Associated Dysfunction
Uchigashima, M., Cheung, A., & Futai, K. (2021) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2021.749164 · Cited by 95
Endocannabinoids in brain plasticity: Cortical maturation, HPA axis function and behavior
Dow-Edwards, D. L., & Silva, L. (2016) · Brain Research · doi:10.1016/j.brainres.2016.08.037 · Cited by 92
Endocannabinoids, cannabinoids and the regulation of anxiety
Petrie, G. N., Nastase, A. S., Aukema, R. J., & Hill, M. N. (2021) · Neuropharmacology · doi:10.1016/j.neuropharm.2021.108626 · Cited by 91
Consensus paper of the WFSBP task force on cannabis, cannabinoids and psychosis
D’Souza, D. C., Forti, M. D., Ganesh, S., George, T. P., Hall, W., Hjorthøj, C. R., Howes, O. D., Keshavan, M. S., Murray, R. M., Nguyen, T. B., et al. (2022) · The World Journal of Biological Psychiatry · doi:10.1080/15622975.2022.2038797 · Cited by 91
Cannabinoid receptor CNR1 expression and DNA methylation in human prefrontal cortex, hippocampus and caudate in brain development and schizophrenia
Tao, R., Li, C., Jaffe, A. E., Shin, J. H., Deep‐Soboslay, A., Yamin, R., Weinberger, D. R., Hyde, T. M., & Kleinman, J. E. (2020) · Translational Psychiatry · doi:10.1038/s41398-020-0832-8 · Cited by 90
Adverse Social Experiences in Adolescent Rats Result in Enduring Effects on Social Competence, Pain Sensitivity and Endocannabinoid Signaling
Schneider, P., Bindila, L., Schmahl, C., Bohus, M., Meyer-Lindenberg, A., Lutz, B., Spanagel, R., & Schneider, M. (2016) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2016.00203 · Cited by 89
The endocannabinoid system: Overview of an emerging multi-faceted therapeutic target
Chanda, D., Neumann, D., & Glatz, J. F. C. (2018) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2018.11.016 · Cited by 87
Cannabis and Endocannabinoid Signaling in Epilepsy
Katona, I. (2015) · Handbook of experimental pharmacology · doi:10.1007/978-3-319-20825-1_10 · Cited by 86
Self-citation
Endocannabinoid dynamics gate spike-timing dependent depression and potentiation
Cui, Y., Prokin, I., Xu, H., Delord, B., Genet, S., Venance, L., & Berry, H. (2016) · eLife · doi:10.7554/elife.13185 · Cited by 85
The endocannabinoid system in mental disorders: Evidence from human brain studies
Ibarra‐Lecue, I., Pilar-Cuéllar, F., Muguruza, C., Florensa-Zanuy, E., Díaz, Á., Urigüen, L., Castro, E., Pazos, Á., & Callado, L. F. (2018) · Biochemical Pharmacology · doi:10.1016/j.bcp.2018.07.009 · Cited by 84
Comparative biology of pain: What invertebrates can tell us about how nociception works
Burrell, B. D. (2017) · Journal of Neurophysiology · doi:10.1152/jn.00600.2016 · Cited by 83
Endocannabinoid system in psychotic and mood disorders, a review of human studies
Ramesh, R. G., Watts, J. J., & Mizrahi, R. (2020) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2020.110096 · Cited by 83
Neuromodulation and metamodulation by adenosine: Impact and subtleties upon synaptic plasticity regulation
Sebastião, A. M., & Ribeiro, J. A. (2014) · Brain Research · doi:10.1016/j.brainres.2014.11.008 · Cited by 82
Multiple Mechanistically Distinct Modes of Endocannabinoid Mobilization at Central Amygdala Glutamatergic Synapses
Ramikie, T. S., Nyilas, R., Bluett, R. J., Gamble‐George, J., Hartley, N. D., Mackie, K., Watanabe, M., Katona, I., & Patel, S. (2014) · Neuron · doi:10.1016/j.neuron.2014.01.012 · Cited by 81
Self-citation
The endocannabinoid system
Kilaru, A., & Chapman, K. D. (2020) · Essays in Biochemistry · doi:10.1042/ebc20190086 · Cited by 81
Role of Cannabidiol in the Therapeutic Intervention for Substance Use Disorders
Navarrete, F., García‐Gutiérrez, M. S., Gasparyan, A., Austrich-Olivares, A., & Manzanares, J. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.626010 · Cited by 81
Hub and switches: endocannabinoid signalling in midbrain dopamine neurons
Melis, M., & Pistis, M. (2012) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2011.0383 · Cited by 81
Endocannabinoids: Effectors of glucocorticoid signaling
Balsevich, G., Petrie, G. N., & Hill, M. N. (2017) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2017.07.005 · Cited by 82
Endocannabinoids mediate bidirectional striatal spike‐timing‐dependent plasticity
Cui, Y., Paillé, V., Xu, H., Genet, S., Delord, B., Fino, É., Berry, H., & Venance, L. (2015) · The Journal of Physiology · doi:10.1113/jp270324 · Cited by 80
Cannabinoid receptor type-1: breaking the dogmas
Busquets-García, A., Gómez, E. S., Bellocchio, L., & Marsicano, G. (2016) · F1000Research · doi:10.12688/f1000research.8245.1 · Cited by 79
The Potential of Cannabidiol as a Treatment for Psychosis and Addiction: Who Benefits Most? A Systematic Review
Batalla, A., Janssen, H., Gangadin, S. S., & Bossong, M. G. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8071058 · Cited by 79
The Cannabinoid Receptor CB1 Interacts with the WAVE1 Complex and Plays a Role in Actin Dynamics and Structural Plasticity in Neurons
Njoo, C., Agarwal, N. K., Lutz, B., & Kuner, R. (2015) · PLoS Biology · doi:10.1371/journal.pbio.1002286 · Cited by 79
Development of an Activity‐Based Probe and In Silico Design Reveal Highly Selective Inhibitors for Diacylglycerol Lipase‐α in Brain
Baggelaar, M. P., Janssen, F. J., van Esbroeck, A. C. M., den Dulk, H., Allarà, M., Hoogendoorn, S., McGuire, R., Florea, B. I., Meeuwenoord, N. J., van den Elst, H., et al. (2013) · Angewandte Chemie International Edition · doi:10.1002/anie.201306295 · Cited by 79
2-Arachidonoylglycerol Modulation of Anxiety and Stress Adaptation: From Grass Roots to Novel Therapeutics
Bedse, G., Hill, M. N., & Patel, S. (2020) · Biological Psychiatry · doi:10.1016/j.biopsych.2020.01.015 · Cited by 78
Inhibiting degradation of 2-arachidonoylglycerol as a therapeutic strategy for neurodegenerative diseases
Chen, C. (2023) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2023.108394 · Cited by 78
Acute and Non-acute Effects of Cannabis on Human Memory Function: A Critical Review of Neuroimaging Studies
Bossong, M. G., Jager, G., Bhattacharyya, S., & Allen, P. (2014) · Current Pharmaceutical Design · doi:10.2174/13816128113199990436 · Cited by 75
Interacting Cannabinoid and Opioid Receptors in the Nucleus Accumbens Core Control Adolescent Social Play
Manduca, A., Lassalle, O., Sepers, M., Campolongo, P., Cuomo, V., Marsicano, G., Kieffer, B., Vanderschuren, L. J. M. J., Trezza, V., & Manzoni, O. J. J. (2016) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2016.00211 · Cited by 73
The Role of Endocannabinoid Signaling in Cortical Inhibitory Neuron Dysfunction in Schizophrenia
Volk, D. W., & Lewis, D. A. (2015) · Biological Psychiatry · doi:10.1016/j.biopsych.2015.06.015 · Cited by 73
Endocannabinoid-Mediated Long-Term Depression of Afferent Excitatory Synapses in Hippocampal Pyramidal Cells and GABAergic Interneurons
Péterfi, Z., Urbán, G. M., Papp, O. I., Németh, B., Monyer, H., Szabó, G., Erdélyi, F., Mackie, K., Freund, T. F., Hájos, N., et al. (2012) · Journal of Neuroscience · doi:10.1523/jneurosci.1676-12.2012 · Cited by 73
Self-citation
Emotional arousal state influences the ability of amygdalar endocannabinoid signaling to modulate anxiety
Morena, M., Leitl, K. D., Vecchiarelli, H. A., Gray, J. M., Campolongo, P., & Hill, M. N. (2016) · Neuropharmacology · doi:10.1016/j.neuropharm.2016.08.020 · Cited by 73

Authors: Katona, I., & Freund, T. F.
Affiliations: HUN-REN Institute of Experimental Medicine (HU)
ORCID: Katona, István
Freund, Tamás F.
Venue: Annual Review of Neuroscience
Publisher: Annual Reviews
Published: 2012-07-21
Volume: 35
Issue: 1
Pages: 529-558
ISSN: 0147-006X (ISSN-L)
1545-4126
DOI: 10.1146/annurev-neuro-062111-150420
PMC: PMC4273654
OpenAlex: W2168499817
Cited by: 630
References: 183
Citations by year: 2026: 39 · 2025: 35 · 2024: 29 · 2023: 44 · 2022: 53 · 2021: 60 · 2020: 56 · 2019: 32 · 2018: 50 · 2017: 57 · 2016: 34 · 2015: 45 · 2014: 43 · 2013: 41 · 2012: 11
FWCI: 5.19
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Locations: Annual Review of Neuroscience (publishedVersion)
PubMed (publishedVersion)
PubMed Central (acceptedVersion)
Funders: Wellcome Trust (090946)
National Institute of Mental Health (R01MH054671, MH54671)
National Institute of Neurological Disorders and Stroke (R37NS030549, R01NS030549, NS30549)
Topics: Health Sciences › Medicine › Pharmacology (medical) › Cannabis and Cannabinoid Research
Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacological Receptor Mechanisms and Effects
Keywords: endocannabinoid signaling, anandamide, 2-arachidonoylglycerol, signalosome, synaptic plasticity, intracellular signaling, cell type-specific signaling, brain
MeSH terms: Animals, Arachidonic Acids, Behavior, Animal, Brain, Glycerides, Humans, Ligands, Models, Neurological, Synaptic Transmission, Neuronal Plasticity, Signal Transduction, Receptors, Cannabinoid, Polyunsaturated Alkamides, Endocannabinoids

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Multiple Functions of Endocannabinoid Signaling in the Brain

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks